Home AEC Sonoma Biotherapeutics to Occupy 83,000 SQFT R&D Development in Seattle
AECFinanceIndustry NewsLife ScienceNews Releases

Sonoma Biotherapeutics to Occupy 83,000 SQFT R&D Development in Seattle

Share
Share

SEATTLE, Wash. –  Cushman & Wakefield and JLL today jointly announced that the firms have represented Sonoma Biotherapeutics, Inc. in a long-term lease agreement to develop an approximately 83,000-square-foot Research and Development (R&D) and Manufacturing Center in Seattle, Washington. Sonoma Bio is a clinical-stage biotechnology company focused on developing engineered regulatory T cell (Treg) therapies […]

Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Share

2026 Pacific Northwest CRE Rising Stars

PNW CRE Rising Stars

Featured Posts


Recent Posts

Related Articles

Navy Opens Bidding on Multibillion-Dollar Contract for New Dry Dock at Puget Sound Naval Shipyard

The Navy has opened bidding on a multibillion-dollar contract to build a...

Desimone Enterprises Buys 213-Site Vista Del Rio Manufactured Home Community in Vancouver for $30MM

Desimone Enterprises has bought Vista Del Rio, a 213-site, 55-and-older manufactured home...